Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Dynatrace gains on raised RBC target and federal cloud security milestone

Dynatrace gains on raised RBC target and federal cloud security milestone

Dynatrace Inc (NYSE:DT) stock rose 2.1% on Monday following RBC Capital Markets' decision to increase its price target and the company securing a crucial cloud security certification. RBC Capital analyst Matthew Hedberg lifted his price target from $59 to $73, maintaining an "Outperform" rating due to positive channel checks and strong operational momentum after a solid first quarter with 41% organic net new annual recurring revenue growth.

Hedberg highlighted the company's increasing traction in log management, driven by effective go-to-market strategies and a surge in new customer acquisitions. Additionally, artificial intelligence capabilities are gaining traction, offering growth opportunities as demand for unified observability and security solutions expands. Despite a 39% rise in Dynatrace shares since the last quarterly report, RBC Capital remains optimistic about the upcoming second-quarter results and the fiscal year's second half.

The company has also earned "Initial Implementation" status for the Federal Risk and Authorization Management Program (FedRAMP) Class D (High) baseline, a key step toward full certification. This milestone allows federal agencies to deploy Dynatrace's AI-powered platform on their sensitive, unclassified workloads, providing access to AI anomaly detection and integrated application security monitoring.

Positioned among a select group of observability platforms targeting the government's top security tier, Dynatrace continues to expand its presence in sectors such as civilian, defense, and intelligence.

Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at investing.com →

More in Finance & Markets

Monday's ETF Movers: IHI, REMX

In trading on Monday, the iShares U.S. Medical Devices ETF is outperforming other ETFs, up about 1.6% on the day. Components of that ETF showing particular strength include shares of Procept…

More from Monday 12 October →